GB9701374D0 - Purinergic agonists and antagonists - Google Patents

Purinergic agonists and antagonists

Info

Publication number
GB9701374D0
GB9701374D0 GBGB9701374.2A GB9701374A GB9701374D0 GB 9701374 D0 GB9701374 D0 GB 9701374D0 GB 9701374 A GB9701374 A GB 9701374A GB 9701374 D0 GB9701374 D0 GB 9701374D0
Authority
GB
United Kingdom
Prior art keywords
antagonists
purinergic agonists
purinergic
agonists
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB9701374.2A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Liverpool
Original Assignee
University of Liverpool
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Liverpool filed Critical University of Liverpool
Priority to GBGB9701374.2A priority Critical patent/GB9701374D0/en
Publication of GB9701374D0 publication Critical patent/GB9701374D0/en
Priority to AU56747/98A priority patent/AU5674798A/en
Priority to PCT/GB1998/000205 priority patent/WO1998032429A2/en
Pending legal-status Critical Current

Links

GBGB9701374.2A 1997-01-23 1997-01-23 Purinergic agonists and antagonists Pending GB9701374D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB9701374.2A GB9701374D0 (en) 1997-01-23 1997-01-23 Purinergic agonists and antagonists
AU56747/98A AU5674798A (en) 1997-01-23 1998-01-23 P2 receptor agonists, antagonists and modulators of endogenous atp release
PCT/GB1998/000205 WO1998032429A2 (en) 1997-01-23 1998-01-23 P2 receptor agonists, antagonists and modulators of endogenous atp release for the treatment of skin conditions and the improvement of wound healing

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9701374.2A GB9701374D0 (en) 1997-01-23 1997-01-23 Purinergic agonists and antagonists

Publications (1)

Publication Number Publication Date
GB9701374D0 true GB9701374D0 (en) 1997-03-12

Family

ID=10806475

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9701374.2A Pending GB9701374D0 (en) 1997-01-23 1997-01-23 Purinergic agonists and antagonists

Country Status (3)

Country Link
AU (1) AU5674798A (en)
GB (1) GB9701374D0 (en)
WO (1) WO1998032429A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0120704D0 (en) * 2000-09-01 2001-10-17 Glaxo Group Ltd Polypeptide
FR2826278B1 (en) * 2001-06-20 2005-03-25 Lipha USE OF ANTIDIABETIC AGENTS FOR MANUFACTURING A MEDICAMENT HAVING A HEALING EFFECT
ATE346601T1 (en) * 2001-06-20 2006-12-15 Merck Sante Sas USE OF ANTIDIABETIC DRUGS FOR THE PRODUCTION OF A SCARING PROMOTING MEDICINAL PRODUCT
ES2614405T3 (en) 2002-04-09 2017-05-31 Otsuka Pharmaceutical Co., Ltd. Composition for cell proliferation
WO2004084895A2 (en) * 2003-03-27 2004-10-07 Medicure, Inc. Modulation of cell death
TW200514575A (en) 2003-10-08 2005-05-01 Otsuka Pharma Co Ltd Promoting composition for collagen producing
ATE509623T1 (en) 2004-06-28 2011-06-15 Ajinomoto Kk NUTRIENT COMPOSITION AND COMPOSITION FOR PREVENTION/MITIGATION OF DIGESTIVE TRACT DEPRESSION

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2844103B2 (en) * 1990-02-09 1999-01-06 株式会社コーセー External preparation for skin

Also Published As

Publication number Publication date
WO1998032429A3 (en) 1999-04-01
AU5674798A (en) 1998-08-18
WO1998032429A2 (en) 1998-07-30

Similar Documents

Publication Publication Date Title
IL133377A0 (en) Glucagon antagonists/inverse agonists
HK1039963A1 (en) Il-2 selective agonists and antagonists
HUP0102535A3 (en) Cd19xcd3 specific polypeptides and uses thereof
EP1032377A4 (en) Substituted 2-aminoacetamides and the use thereof
IL130660A0 (en) Benzothiophenecarboxamide derivatives and PGD2 antagonists comprising them
ZA974147B (en) Somatostatin agonists and antagonists.
HUP0002704A3 (en) Gnrh antagonists being modified in positions 5 and 6
IL141050A0 (en) Muscarinic agonists and antagonists
IL132903A0 (en) N-triazolyl-2-indolecarboxamides and their their use as cck-a agonists
GB9701374D0 (en) Purinergic agonists and antagonists
EP1073458A4 (en) Chlamydia proteins and their uses
HUP0004317A3 (en) 5-ht1f agonists
GB9820014D0 (en) Receptor antagonists and uses thereof
HUP0104723A3 (en) New 2-aminothiazol-fused 2-aminoindans and 2-aminotetralins and their use
IL123535A0 (en) Benzoxazindione derivatives and their use
PL307138A1 (en) Amyline antagonists and agonists
EP0998578A4 (en) Sel-10 AND USES THEREOF
ZA984896B (en) Carbohydrates and use thereof
PL341293A1 (en) Beta-lypothropin and application thereof
GB9722392D0 (en) Composition and use
ZA985759B (en) Glucagon antagonists/inverse agonists
ZA988065B (en) Pyrimidin-2-oxy-4-one and pyrimidin-2-oxy-4-thione derivatives
AUPP058597A0 (en) Receptor agonists and antagonists
GB9712961D0 (en) Composition and use
GB9722390D0 (en) Composition and use